Kevzara subcutaneous injection 200mg syringe, manufactured by Sanofi, contains Sarilumab (genetical recombination) (YJ code: 3999444G2029, 200mg 1.14mL 1 tube). This IL-6 receptor antagonist is used for moderately to severely active rheumatoid arthritis in adults who have had an inadequate response or intolerance to other DMARDs.
Kevzara subcutaneous injection 200mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →